2008
DOI: 10.1158/0008-5472.can-08-1468
|View full text |Cite
|
Sign up to set email alerts
|

Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment

Abstract: Chemically functionalized single-walled carbon nanotubes (SWNT) have shown promise in tumor-targeted accumulation in mice and exhibit biocompatibility, excretion, and little toxicity. Here, we show in vivo SWNT drug delivery for tumor suppression in mice. We conjugate paclitaxel (PTX), a widely used cancer chemotherapy drug, to branched polyethylene glycol chains on SWNTs via a cleavable ester bond to obtain a water-soluble SWNT-PTX conjugate. SWNT-PTX affords higher efficacy in suppressing tumor growth than c… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

16
783
0
6

Year Published

2009
2009
2017
2017

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 1,217 publications
(805 citation statements)
references
References 46 publications
(106 reference statements)
16
783
0
6
Order By: Relevance
“…There are no FDA approvals or clinical trials in process up to date using carbon nanotubes, although the encouraging preclinical results in vitro and in vivo in cancer treatment via passive targeting show that this structures are promising nanocarriers for cancer treatment [18,126,296,297,300,[307][308][309][310][311][312][313][314][315][316]. Active tumor targeting has been rarely reported in vivo [300,317,318], usually without drug loading [301,303,319].…”
Section: Carbon Nanotubesmentioning
confidence: 99%
“…There are no FDA approvals or clinical trials in process up to date using carbon nanotubes, although the encouraging preclinical results in vitro and in vivo in cancer treatment via passive targeting show that this structures are promising nanocarriers for cancer treatment [18,126,296,297,300,[307][308][309][310][311][312][313][314][315][316]. Active tumor targeting has been rarely reported in vivo [300,317,318], usually without drug loading [301,303,319].…”
Section: Carbon Nanotubesmentioning
confidence: 99%
“…Firstly 1 g raw MWCNT were treated in 120 mL concentrated HNO 3 and H 2 SO 4 (1:3, v/v) solution at 120°C in an oil bath for 30 min [34]. After dilution with water by 10-fold, the solution was filtered through a 0.45 lm filter.…”
Section: Preparation Of Nanocarriersmentioning
confidence: 99%
“…Carbon nanotubes (CNTs), as molecule carriers, exhibit potential in biological systems due to their distinct properties in cell membrane penetration, and loading and release of molecular cargoes [1][2][3][4][5]. Moreover, it has been discovered that CNTs could be metabolized by neutrophil myeloperoxidase [6] and the functionalized CNTs (f-CNTs) have less cytoxicity [7].…”
Section: Introductionmentioning
confidence: 99%
“…One of the potential solutions to overcome these problems is the compaction of siRNA by synthetic gene delivery systems (Mintzer and Simanek 2009). siRNA compaction can be accomplished by using a non-viral delivery carrier such as linear or branched cationic polymer (dendrimer) (Tsubouchi et al 2002;Duxbury et al 2003;Grayson et al 2006) and CNTs (Lu et al 2004;Liu et al 2007Liu et al , 2008Liu et al , 2009.…”
Section: Introductionmentioning
confidence: 99%